How Will AC Immune’s Phase II Fail Impact Alzheimer’s Research?
AC Immune and Genentech’s drug has failed to slow the progression of Alzheimer’s disease in…
29/09/2020 - 6 minutes
AXON Neuroscience
Two European Alzheimer’s Disease Treatments Show Promise in Phase II
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in…
09/04/2020 - 4 minutes
Where Others Failed, a Vaccine for Dementia Shows Potential in the Clinic
AXON Neuroscience has presented positive clinical results for its Alzheimer's vaccine and announced a new…
04/04/2017 - 3 minutes
World Mental Health Day: How is Biotech Helping the Cause?
Biotech is one of the main forces driving the development of effective therapies to treat neurological and…
11/10/2016 - 4 minutes
Alzheimer’s closer to a Vaccine with new Slovakian Phase II Trial
Axon Neuroscience is starting a Phase II trial with its immunotherapy for Alzheimer's disease, which…
23/06/2016 - 2 minutes
5 Cool Biotechs in Eastern Europe
Eastern Europe is home to fascinating culture and rising economies, but how is the Biotech…
22/03/2016 - 3 minutes
